This is a preview of subscription content, log in via an institution to check access.
Reference
Pollock RF, et al. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in Therapy : 19 Nov 2018. Available from: URL: http://doi.org/10.1007/s12325-018-0827-5
Rights and permissions
About this article
Cite this article
Switch from Ferinject to Monofer reduces infusions and costs. PharmacoEcon Outcomes News 818, 29 (2018). https://doi.org/10.1007/s40274-018-5527-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5527-5